Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis

por Prins, Kurt W., Duval, Sue, Markowitz, Jeremy, Pritzker, Marc, Thenappan, Thenappan
Publicado 2017

Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients

por Holthaus, Nathan, Prins, Kurt W., Rose, Lauren, Prisco, Sasha, Pritzker, Marc, Thenappan, Thenappan
Publicado 2019

Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

por Thenappan, Thenappan, Weir, E. Kenneth, Prins, Kurt W, Pritzker, Marc R., Archer, Stephen L.
Publicado 2021

Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again

por Prins, Kurt W., Thenappan, Thenappan, Weir, E. Kenneth, Kalra, Rajat, Pritzker, Marc, Archer, Stephen L.
Publicado 2018

Comparison of Balloon Pulmonary Angioplasty and Pulmonary Vasodilators for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis

por Kalra, Rajat, Duval, Sue, Thenappan, Thenappan, Raveendran, Ganesh, Pritzker, Marc, Prisco, Sasha Z., Prins, Kurt W.
Publicado 2020

Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease

por Prins, Kurt W., Rose, Lauren, Archer, Stephen L., Pritzker, Marc, Weir, E. Kenneth, Olson, Matthew D., Thenappan, Thenappan
Publicado 2019

Heart Failure Hospitalization Trends During the Early Phase of the COVID 19 Pandemic

por Fraser, Meg, Mutschler, Melinda, Sackman, Kerry, Newman, Christie, Alexy, Tamas, Garry, Daniel, Kamdar, Forum, Thenappan, Thenappan, Pritzker, Marc, Martin, Cindy M., Cogswell, Rebecca
Publicado 2020

Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension

por Chang, Kevin Y., Giorgio, Katherine, Schmitz, Katlin, Walker, Rob F., Prins, Kurt W., Pritzker, Marc R., Archer, Stephen L., Lutsey, Pamela L., Thenappan, Thenappan
Publicado 2023

Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies

por Thenappan, Thenappan, Al-Naamani, Nadine, Ghio, Stefano, Ghofrani, Hossein-Ardeschir, Hassoun, Paul M., Pritzker, Marc, Torbicki, Adam, Nikkho, Sylvia, Busse, Dennis, Preston, Ioana R.
Publicado 2020

Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension

por Prins, Kurt W., Kalra, Rajat, Rose, Lauren, Assad, Tufik R., Archer, Stephen L., Bajaj, Navkaranbir S., Weir, E. Kenneth, Prisco, Sasha Z., Pritzker, Marc, Lutsey, Pamela L., Brittain, Evan L., Thenappan, Thenappan
Publicado 2020